← Open Payments lookup

MATTHEW LEHNER-GULOTTA: Open Payments

NPI 1801675517 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$287 in 13 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $188 · 2025 $287

Food & beverage: $287
CompanyPaymentsAmount
ABBVIE INC.3$62
PFIZER INC.2$44
Biogen, Inc.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Amgen Inc.1$26
Otsuka America Pharmaceutical, Inc.1$24
Merck Sharp & Dohme LLC1$22
Dexcom, Inc.1$20
Lilly USA, LLC1$19
Exact Sciences Corporation1$17

Products named: QULIPTA, PREVNAR 20, SKYCLARYS, CAPLYTA, OTEZLA, REXULTI, GARDASIL 9, Dexcom G6 Transmitter.

Industry payments across VA — which companies pay providers there.